Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just get on your FB and search for potnetwork. UTRM
Hey Bux, just hit me.....what if the screen shot was a screen shot of the VIDEO LETTER being recorded???
In the encapsulated ImenVax™ device, a "cocktail" of integral immuno-catalysts are enclosed. From this ImenVax™ device immuno-catalysts are released which activate the patient's immune cell. These immune cells carry on their normal course of activity by entering the lymph nodes and cause T-Cell adaptation. These T-Cells are what attack and kill the tumor. (Figure 1)
Entest BioMedical Inc. (OTCQB: ENTB)is a majority owned subsidiary of Bio-Matrix Scientific Group Inc (OTCQB: BMSN). The Company is involved with the development of stem cell therapy treatments for Chronic Obstructive Pulmonary Disease (COPD), cancer immuno-therapies, testing procedures for diabetes and stem cell research applications for diabetes and other illnesses. The Company also is involved with medical device development (including stem cell extraction instrumentation).
Currently, Entest is focused on research and development in areas of COPD and Immuno-Therapeutic Cancer Vaccines. The Company sees applications for its patent pending technologies in both human and animal venues.
Immuno-therapeutic treatment of cancer - The patent pending Entest application involves perfecting the use of cell lines for sustained release of immunologically relevant cytokines for maximum anti-tumor immune responses in treating cancer. The treatment process itself will utilize an implantable encapsulation device as the vaccine delivery system and the initial focus will be treatment of cancer in canines. This canine cancer treatment may also provide clinical support for expansion into human cancer treatment.
Chronic Obstructive Pulmonary Disease -There is currently no cure for COPD and therapy is limited to management of the condition and its symptoms. Over the next 5 years, it is estimated that over $170 billion will be spent on treating COPD in the United States. Entest believes its COPD treatment, which utilizes patent pending adult stem cell therapy coupled with photoceutical device enhancement, has the potential to reverse COPD related lung damage as well as alleviate symptoms.
Entest BioMedical was founded for the purpose of providing excellence in biotechnology research (including adult stem cell regenerative treatment). Our objectives go beyond developing single products and procedures. Our mission is to discover and develop new procedures, treatments and medical devices that improve the quality of life. Our efforts revolve around a business focus of developing leading research and technology. Ongoing R&D is paramount to us in developing products and procedures with purpose, products and services that serve the present and help shape the future.
Management:
David R. Koos, PhD, DBA - Chairman and CEO, Secretary, Acting CFO
Feng Lin, MD, PhD - Director of Research
Marilyn Panahi - Director of Quality Assurance
And Hopefully a MILLION BUCKS!!! GO UTRM
UTRM... WE ARE GOING GREEN THREE DAYS IN A ROW!!!! UTRM
Nope, I'm in for as much as I want and need to be, nice one though, feel better?
I bought last friday with my TD account, no problems
Thats bullsheet that they took time out of their letter writing to do this stuff!!
This could be the dumbest post I've ever seen. No offense
Thanks TF
I agree, I just follow the boards of a few positions I have and it's the same on every one of them....WHERE"S THE NEWS?....every day. I owned for Ford for two years and looked at it once a month, never worried about PR's, sold it for a nice little profit. Point is I'm not a day trader ( not yet, maybe when I have a little more disposable cash) so I do some DD, take a chance on what I can/will risk and sit back for a while. If I think it's getting shady I bale. But to sit on a board and whine all day is nonsense. JMO
Do you want to invest in a MJ Media company or a PRESS RELEASE company WTF!!UTRM
I'm scrambling hear this morning trying to get more money in acct. to pick up more ENTB before blast off
I like the sound of that. GO ENTB!!!!!!!!
Dam, wish I could free up some more bank! ENTB
that twitter link wont load for me.ENTB
Wishful thinking, or maybe just all the cough syrup
This is great, I can finally get coverage for those dam mites!! UTRM
Maybe the "televised" letter will be read on mad money!! UTRM
$$UTRM Who needs a 401 when we got 420??
I know that none of you know me but can someone lend me a bunch of money to buy some more UTRM?? I'll pay you back next week!! LOL
Hopefully UTRM will be at 2 bux contributing to my retirement!!
If we can, I want next week sometime for 150 Billion!! I'm tired of dreaming small!! VPLM
I know you didn't ask me but I'm pretty small time, got about 8K spread out over a few positions, picked up 1 mil of ENTB last week in two chunks for a 9 average. Got 20k shares of another one at .19 that we're waiting for a buyout in the $2-5 range, if that happens soon I will load up more ENTB. Then I got a couple Fad MJ positions. sorry if this was too off topic. Go ENTB!!
Not Friday, markets closed
Hey, I'm not throwing in the towel until midnight!! lol
Potnetwork.tv There is a shareholder letter still to come. If you still haven't signed up on our email list please do so with Jodi: jodi@asaustincompany.com
Like · Reply · 8 · 30 minutes ago
Who else would he meet with? The janitors??
Why is the A/S still 6B? I'm a novice don't yell, lol
Could be a first time, HAPPY HAPPY Tax Day!!!!!!!!
So how many O/S are outstanding? My TD account shows 5.6B
I don't see how a vending machine could work, there is a legal age even where it is legal. Same reason beer is not in vending machines. It will need to be over the counter to check ID. At least the THD stuff
Mighty quiet around here today, is that good or bad?? (or neither)
TD says 1.3M with a market cap of 7.3K
I thought it was 3 Billion??
And this was the PR AS PROMISED on the 9th
United Treatment Centers Inc. (OTC Pink: UTRM): DBA www.PotNetwork.tv Closes First Round of Financing and Announces Website/Video Launch Date 4/20/2014
4/9/14 8:32 AM ET (Market Wire)Print
United Treatment Centers Inc. (OTC Pink: UTRM) (PINKSHEETS: UTRM) DBA www.PotNetwork.tv: "We have closed our first round of financing and will launch full scale website/video operations on 4/20/2014. After fielding several offers, we have put together a structure that enhances shareholder value and is commensurate with our long term objectives. I truly apologize for our radio silence, I was advised by counsel to suspend communications until financing was finalized. We will always operate in an accountable and transparent manner," Chris Seminatore, CEO of United Treatment Centers, Inc. stated.
"The size and scope of the website and video production has grown exponentially. We have integrated several educational and business service components which will substantially increase web presence and shareholder value. We couldn't ask for a better date to kick off operations," Mr. Seminatore added.
PotNetwork.tv is designed to be the CNN of the marijuana industry. Daily video programming will cover:
-- New Product Development
-- Product Availability in different States
-- Product Quality Analysis by Growers
-- Where it can be purchased in particular states
-- Rules of use and transport
-- Interviews with CEOs of publicly trading marijuana stocks
-- Marijuana market reports and analysis
-- Interviews with attorneys who are well-versed in marijuana related
issues
-- Celebrities supporting marijuana related causes
-- Informational videos featuring all aspects of cultivation
-- General news and updates on the marijuana industry
-- Farming reports
-- Price analysis
From crop reports to stock reports, www.potnetwork.tv is your source for marijuana news.
"Safe Harbor Statement" under the Private Securities Litigation Reform Act of 1995. This press release contains forward-looking statements that involve risks and uncertainties. The statements in the Release are forward-looking statements that are made pursuant to safe harbor provision of the Private Securities Litigation Reform Act of 1995. Actual results, events and performance could vary materially from those contemplated by these forward-looking statements.
CONTACT:
Investor Relations Contact Information
United Treatment Centers Inc.
Andrew Austin
858-537-7439
Andy@potnetwork420.com
SOURCE: United Treatment Centers, Inc.